메뉴 건너뛰기




Volumn 11, Issue 3, 2001, Pages 497-503

Removal and inactivation of viruses during manufacture of a high purity antihemophilic factor VIII concentrate from human plasma

Author keywords

Antihemophilic factor VIII; Immunoaffinity chromatography; Virus removal and inactivation

Indexed keywords

BLOOD CLOTTING FACTOR 8 CONCENTRATE; DETERGENT; GREENMONO; MONOCLONAL ANTIBODY; ORGANIC SOLVENT; PHOSPHATE; SEPHAROSE; TRITON X 100;

EID: 0034928574     PISSN: 10177825     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article
Times cited : (10)

References (27)
  • 5
    • 0028229490 scopus 로고
    • Removal and inactivation of hepatitis A virus (HAV) during processing of factor VIII concentrates
    • (1994) Vox Sang. , vol.67 , Issue.SUPPL. 1 , pp. 72-77
    • Hamman, J.1    Zou, J.2    Horowitz, B.3
  • 7
    • 0025610739 scopus 로고
    • Blood protein derivative viral safety: Observations and analysis
    • (1990) Yale J. Med. , vol.63 , pp. 361-369
    • Horowitz, B.1
  • 11
    • 0032564029 scopus 로고    scopus 로고
    • Guidance on viral safety evaluation of biotechnology products derived from cell lines of human or animal origin
    • International Conference on Harmonisation.
    • (1998) Federal Register , vol.63 , pp. 51074-51084
  • 18
    • 0027255828 scopus 로고
    • Clinical evaluation of viral safety of coagulation factor VIII and IX concentrates
    • (1993) Vox Sang. , vol.64 , pp. 197-203
    • Mannucci, P.M.1


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.